Nanotechnology for Cancer

Cancer is one of the most common chronic diseases in man that accounts for 14 million new cancer cases and 8 million deaths per year worldwide. In recent years, nanotechnology shows potential promise in the management of cancer. Nanoparticles attached to cancer marker targeted antibodies could detect cancer at earlier phases of cancer development, better than existing methods. Theoretical physicist Richard Feynman in 1959 has initiated the science of using nanotechnology, but due to the technical challenges, practical medical applications has taken only in the past 10 years or so that the technology has really taken off for.

  • Track 1-1 Nano Materials for Cancer Diagnosis and Therapy
  • Track 2-2 Nanotheranostics for Cancer
  • Track 3-3 RNA Nanotechnology for Cancer Treatment
  • Track 4-4 Target Based Drug Delivery
  • Track 5-5 Nano Colloids
  • Track 6-6 DNA Nanorobot

Related Conference of Nanotechnology